TGA Approval

MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet (352573)

ARTG ID

352573

ARTG Name

MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet

Sponsor

AbbVie Pty Ltd

ARTG Date

February 7, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

https://medical-cdn.nocode.com/drug_tga/e0186bd6e96d38804e509f377c5fb411.pdf

https://medical-cdn.nocode.com/drug_tga/9a040e456036049ca312b1c60c01f043.pdf

Ingredient Name

glecaprevir

Ingredient Name

pibrentasvir

Empowering clinical research with data-driven insights and AI-powered tools.

MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet (352573) - TGA 批准文号 | MedPath